CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity. Cross-linking of CD26 and CD3 with immobilized mAbs can deliver a costimulatory signal that contributes to T cell activation. Our earlier studies revealed that cross-linking of CD26 induces its internalization. the phosphorylation of a number of proteins involved in the signaling pathway. and subsequent T cell proliferation. Although these findings suggest the importance of internalization in the function of CD26, CD26 has only 6 aa residues in its cytoplasmic region with no known motif for endocytosis. In the present study, we have identified the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGFIIR) as a binding protein for CD26 and that mannose 6-phosphate (M6P) residues in the carbohydrate moiety of CD26 are critical for this binding. Activation of peripheral blood T cells results in the mannose 6 phosphorylation of CD26. In addition, the cross-linking of CD26 with an anti-CD26 antibody induces not only capping and internalization of CD26 but also colocalization of CD26 with M6P/IGFIIR. Finally, both internalization of CD26 and the T cell proliferative response induced by CD26-mediated costimulation were inhibited by the addition of M6P, but not by glucose 6-phosphate or mannose l-phosphate. These results indicate that internalization of CD26 after crosslinking is mediated in part by MGP/IGFIIR and that the interaction between mannose 6-phosphorylated CD26 and M6P/IGFIIR may play an important role in CD26-mediated T cell costimulatory signaling.
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Dong, RP
Tachibana, K
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Tachibana, K
Hegen, M
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Hegen, M
Scharpé, S
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Scharpé, S
Cho, D
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Cho, D
Schlossman, SF
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Schlossman, SF
Morimoto, C
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USAHarvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Dong, RP
Tachibana, K
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Tachibana, K
Hegen, M
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Hegen, M
Scharpé, S
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Scharpé, S
Cho, D
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Cho, D
Schlossman, SF
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA
Schlossman, SF
Morimoto, C
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USAHarvard Univ, Sch Med, Div Tumor Immunol, Dana Farber Canc Inst, Boston, MA 02115 USA